Article
PTEN abnormalities predict poor outcome in children with T‐cell acute lymphoblastic leukemia treated according to ALL IC‐BFM protocols
8 Jan 2019
Abstract excerpt
Pediatric T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive malignancy derived from T-cell precursors and represents 10% to15% of childhood acute lymphoblastic leukemia, the most common cancer in children. In T-ALL many recurrent molecular lesions, for example, alterations affecting NOTCH1, PI3K/PTEN/AKT/mTOR, or JAK-STAT signaling pathways, hold promise for genetic-based risk stratification and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
